{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:45:15Z","timestamp":1759365915926,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.humimm.2019.11.008","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:29:08Z","timestamp":1575282548000},"page":"151-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma soluble HLA-G levels in a cohort of heart failure patients exposed to chemicals"],"prefix":"10.1016","volume":"81","author":[{"given":"Daria","family":"Bortolotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarita","family":"Stendardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Fucili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piera","family":"Boschetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2019.11.008_b0005","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.humimm.2019.11.008_b0010","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2019.11.008_b0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: An overview","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.humimm.2019.11.008_b0020","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/657625","article-title":"Some basic aspects of HLA-G biology","volume":"2014","author":"Alegre","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2019.11.008_b0025","first-page":"99","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2019.11.008_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2019.11.008_b0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association","volume":"68","author":"Donadi","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2019.11.008_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.humimm.2005.12.003","article-title":"Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression","volume":"67","author":"Hviid","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.11.008_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0039.2008.01107.x","article-title":"The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma","volume":"72","author":"Chen","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2019.11.008_b0050","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.humimm.2013.03.003","article-title":"The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3\u2019-untranslated region","volume":"74","author":"Svendsen","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.11.008_b0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1471-4906(01)02007-5","article-title":"HLA-G: a shield against inflammatory aggression","volume":"22","author":"Carosella","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.humimm.2019.11.008_b0060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1096\/fj.04-1617fje","article-title":"HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells","volume":"19","author":"LeMaoult","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.humimm.2019.11.008_b0065","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.humimm.2011.08.016","article-title":"Human leukocyte antigen-G is upregulated in heart failure patients: a potential novel biomarker","volume":"72","author":"Almasood","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.11.008_b0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/1354750X.2015.1118545","article-title":"Hemostatic, inflammatory, and oxidative markers in pesticide user farmers","volume":"21","author":"Madani","year":"2016","journal-title":"Biomarkers"},{"key":"10.1016\/j.humimm.2019.11.008_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/oemed-2011-100347","article-title":"Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers","volume":"69","author":"Sauni","year":"2012","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.humimm.2019.11.008_b0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tox.2016.11.001","article-title":"IL-6, a central acute-phase mediator, as an early biomarker for exposure to zinc-based metal fumes","volume":"373","author":"Baumann","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.humimm.2019.11.008_b0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/heartjnl-2018-313463","article-title":"Association of occupational exposures with cardiovascular disease among US Hispanics\/Latinos","volume":"105","author":"Bulka","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.humimm.2019.11.008_b0090","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.humimm.2019.11.008_b0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1399-0039.2011.01830.x","article-title":"A fast and easy real-time PCR genotyping method for the HLA-G 14-bp insertion\/deletion polymorphism in the 3' untranslated region","volume":"79","author":"Djurisic","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2019.11.008_b0100","doi-asserted-by":"crossref","first-page":"8417190","DOI":"10.1155\/2016\/8417190","article-title":"Upregulation of soluble HLA-G in chronic left ventricular systolic dysfunction","volume":"2016","author":"Olesen","year":"2016","journal-title":"J. Immunol. Res."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:52:15Z","timestamp":1759319535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919313539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0198885919313539"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2019.11.008","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma soluble HLA-G levels in a cohort of heart failure patients exposed to chemicals","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2019.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}